Transition report pursuant to Rule 13a-10 or 15d-10

Cover

v3.22.1
Cover - USD ($)
 4 Months Ended
Dec. 31, 2021
Mar. 18, 2022
Jun. 30, 2021
Document Information Line Items      
Entity Registrant Name Artelo Biosciences, Inc.    
Entity Central Index Key 0001621221    
Document Type 10-KT    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --08-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2021    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus Q1    
Document Fiscal Year Focus 2022    
Entity Common Stock Shares Outstanding   42,301,013  
Entity Public Float     $ 28,499,602
Document Period Start Date Sep. 01, 2021    
Document Annual Report false    
Document Transition Report true    
Entity File Number 001-38951    
Entity Incorporation State Country Code NV    
Entity Tax Identification Number 33-1220924    
Entity Address Address Line 1 505 Lomas Santa Fe    
Entity Address Address Line 2 Suite 160    
Entity Address City Or Town Solana Beach    
Entity Address State Or Province CA    
Entity Address Country US    
Entity Address Postal Zip Code 92075    
City Area Code 858    
Icfr Auditor Attestation Flag false    
Auditor Name MaloneBailey, LLP    
Auditor Location Houston, Texas    
Local Phone Number 925-7049    
Security 12b Title Common Stock, $0.001 par value per share    
Trading Symbol ARTL    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Firm Id 206    
Warrants [Member]      
Document Information Line Items      
Security 12b Title Warrants    
Trading Symbol ARTLW    
Security Exchange Name NASDAQ